Birmingham, Ala-based hospice pharmacy service DeliverCareRx has expanded its footprint with a new facility in southern New Jersey. The location will make pharmacy deliveries and provide other services throughout New Jersey, the Philadelphia metropolitan area and other regions in the Northeastern United States.
The move is part of the company’s overall growth strategy to expand its services nationwide.
“This is another exciting step in our strategic growth plan and how we best service our hospice partners and their patients in the Northeastern United States,” said DeliverCareRx Vice President Jason Kimbrel. “Our goal is to provide hospice patients with convenience and easy access to their medications.
DeliverCareRx expanded to the West Coast last month with a de novo location in Livermore, Calif., serving the Bay Area. The New Jersey location in addition to medication delivery will also offer non-sterile compounding, pre-filled syringes, pharmacy consulting as well as automated and non-automated IPU services.
New Jersey ranks 39th in the nation in hospice utilization. More than 44% of Medicare decedents in the state elected hospice during 2017, according to the National Hospice and Palliative Care Association. About 16% of the state’s population is older than 65. By 2030, that number is expected to rise above 25%, per the U.S. Census Bureau.
Pennsylvania, parts of which the new facility will also serve, had a 48% utilization rate in 2017. Utah has the highest rate of utilization at 59.4%.
“DeliverCareRx is very excited to open our new state of the art New Jersey pharmacy solely specialized on serving hospices and hospice patients,” said Dave Krishna, president and CEO of DeliverCareRx. “Our leadership team is from New Jersey and has a long history serving the hospice community with a best in class customer service model. The DeliverCareRx home delivery and in-patient unit (IPU) models and our PBM partnership have proven to be a game changer for hospices throughout the country. This new facility will allow us to offer further cost savings and increased services to all hospices throughout the state of New Jersey, Philadelphia and entire Northeastern US.”